Zymeworks rejects ‘unsolicited, opportunistic’ buyout bid by UAE-based All Blue Falcons
Shares of Zymeworks Inc. rallied 1.5% in morning trading Friday, after the biopharmaceutical company said it rejected the "unsolicited, opportunistic, non-binding" $10.50-per-share buyout bid by...